WHAT IS THE WORLD BIOSIMILAR CONGRESS?

 

CONFERENCE

NETWORKING 

Biosimilar 2016 panel discussion

The World Biosimilar Congress is a commercially focused event bringing together the full value chain and located in one of the world’s major life science hubs, Basel. Consisting of thought-leaders from across the globe, the World Biosimilar Congress looks at commercialising and pushing forward the adoption of biosimilars globally. Over the last 5 years, the Congress has built up a reputation for delivering high level content and bringing together the senior executives from sourcing through to patient. It is co-located with the European Antibody Congress, World Immunotherapy Congress, and HPAPI World Congress.

Biosimilar 2016 panel discussion

The World Biosimilar Congress recognises the importance of networking and offers an experience which allows you to do just that. With a series of round table discussions, speed networking, networking drinks receptions, breaks and lunches, we provide you with plenty of opportunities to have those all important conversations. With multiple networking formats we enable you to have casual chats and introductions without compromising your time attending the conference sessions.

 

DOWNLOAD THE PROSPECTUS

"This is an excellent strategic conference on the global development of biosimilars and should be attended by anyone developing biosimilars."


N.D.A. Regulatory Science Ltd

KEY SPEAKERS AT THE WORLD BIOSIMILAR CONGRESS 2016 INCLUDED: 

 

  • Ms Emily Alexander at World Biosimilar Congress
    Ms Emily Alexander
    Director of External Affairs, Biologics Strategic Development
    AbbVie
    Mr Brian Edwards at World Biosimilar Congress
    Mr Brian Edwards
    Principal Consultant
    N.D.A. Regulatory Science
  • Mr Laurent Rebier at World Biosimilar Congress
    Mr Laurent Rebier
    Director Business Development
    Merck
    Dr Andrew Reason at World Biosimilar Congress
    Dr Andrew Reason
    CEO and MD
    BioPharmaSpec Inc.
  • Michael Reilly at World Biosimilar Congress
    Michael Reilly
    Executive Director
    Alliance for Safe Biologic Medicines
    Dr Steffen Thirstrup at World Biosimilar Congress
    Dr Steffen Thirstrup
    Director, NDA Regulatory Advisory Board
    NDA Advisory Services Ltd
  • Sean Barry at World Biosimilar Congress
    Sean Barry
    Pharmaceutical Assessor
    Health Products Regulatory Authority, Ireland
    Mr Alex Kudrin at World Biosimilar Congress
    Mr Alex Kudrin
    Vice President & Head, Global Development
    Celltrion
  • Mr Tim Shea at World Biosimilar Congress
    Mr Tim Shea
    Director
    Sterne Kessler Goldstein And Fox Plc
    Mr Alex Waldron at World Biosimilar Congress
    Mr Alex Waldron
    VP, Global Commercial Operations
    Epirus Biopharmaceuticals

SEE ALL 2016 SPEAKERS

col-md-1

WHO ATTENDS?

 

Bayer Pharma AG G.E Helthcare Janssen Takeda Express Scripts Inc Merck Bio Rad Laboratories Cellitron Terumo  Europa Bioproducts Amgen Sandoz Biogen PAREXEL Merck Millipore Boehringer Ingelheim Abbvie Ag Quintiles  Alexion Pharma Pfizer Roche Myoderm Fujifilm Kyowa Kirin Biologics Alliance for Safe Biologic Medicines NDA Group Sterne Kessler Goldstein And Fox Plc Prozyme  Cinfa Biotech  ExcellGene Orion Pharma Altran Deallus  Prozyme   A.L.S. Automated Lab Solutions Resindion srl McKinsey & Company Genzyme IMS Health MSPharma Daiichi Sankyo INC Research Hospira R-Pharm ProBioGen  Novo Nordisk Pharmatech Bionical Ltd Alvotech Wyatt Health Management Promogen-MAB BioXpress Therapeutics Dr. Reddy's Laboratories SA University of Oslo  Asterand Avrentim Johnson and Johnson Probiomed  Vantage Health Hoffman La Roche  Probiomed  MedImmune InSight Biopharmaceuticals

col-md

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Partner with the world biosimilar congress:

Forge new partnerships

generate new leads

build your brand presence

 

DOWNLOAD PROSPECTUS

"Great conference. Great planning, execution and very responsive throughout the process."

 

Executive Director - Global Colon Cancer Association

 

bioismilar prospectus 2017

 


PUT YOUR COMPANY AT THE FOREFRONT OF THE BIOSIMILAR INDUSTRY

 

Download the prospectus to find out different ways you can get involved in the most important biosimilar meeting in europe.

 

DOWNLOAD PROSPECTUS